Filippo Mariano

Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Real-World Evidence: Cefiderocol Therapeutic Drug Monitoring in Critically Ill, Obese Patients with Klebsiella pneumoniae Infections.

Real-World Evidence: Cefiderocol Therapeutic Drug Monitoring in Critically Ill, Obese Patients with Klebsiella pneumoniae Infections.

Journal: Antibiotics (Basel, Switzerland)

Published: May 20, 2026

CytoSorb in burn patients with septic shock and acute kidney injury on continuous kidney replacement therapy efficiently reduces the levels of Gram-negative-derived quorum-sensing molecules associated with lactate increases.

CytoSorb in burn patients with septic shock and acute kidney injury on continuous kidney replacement therapy efficiently reduces the levels of Gram-negative-derived quorum-sensing molecules associated with lactate increases.

Journal: Burns : journal of the International Society for Burn Injuries

Published: April 11, 2026

Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials.

Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials.

Journal: Med (New York, N.Y.)

Published: August 13, 2025

CD42-Enriched Extracellular Vesicles Contribute to Increased Platelet Aggregation and Possibly Organ Damage in Patients with Burn Injury Complicated by Sepsis.

CD42-Enriched Extracellular Vesicles Contribute to Increased Platelet Aggregation and Possibly Organ Damage in Patients with Burn Injury Complicated by Sepsis.

Journal: International journal of nanomedicine

Published: May 30, 2025

Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes.

Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes.

Journal: Frontiers in immunology

Published: May 15, 2025

Optimizing colistin dosing in patients undergoing continuous kidney replacement therapy: critical considerations for intensivists.

Optimizing colistin dosing in patients undergoing continuous kidney replacement therapy: critical considerations for intensivists.

Journal: Critical care (London, England)

Published: April 05, 2025

LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter Baumannii.

LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter Baumannii.

Journal: Antibiotics (Basel, Switzerland)

Published: March 20, 2025

Sorbents therapies in burn patients with septic shock on continuous kidney replacement therapy: an added value for a selected population.

Sorbents therapies in burn patients with septic shock on continuous kidney replacement therapy: an added value for a selected population.

Journal: Critical care (London, England)

Published: January 14, 2025

Profiling of miRNAs Contained in Circulating Extracellular Vesicles and Associated with Sepsis Development in Burn Patients: A Proof-of-Concept Study.

Profiling of miRNAs Contained in Circulating Extracellular Vesicles and Associated with Sepsis Development in Burn Patients: A Proof-of-Concept Study.

Journal: International journal of molecular sciences

Published: December 30, 2024

Dysfunctional Lipid-Induced Secretion of Glucagon-Like Peptide-2(GLP-2), but Not of Incretins Glucagon-Like Peptide-1(GLP-1)/Glucose-Dependent Insulinotropic Polypeptide(GIP), Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Onset and Progression Through Gut Barrier Disruption and Endotoxemia.

Dysfunctional Lipid-Induced Secretion of Glucagon-Like Peptide-2(GLP-2), but Not of Incretins Glucagon-Like Peptide-1(GLP-1)/Glucose-Dependent Insulinotropic Polypeptide(GIP), Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Onset and Progression Through Gut Barrier Disruption and Endotoxemia.

Journal: MedComm

Published: December 20, 2024

Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva.

Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva.

Journal: Gut microbes

Published: December 02, 2024

Governo clinico in nefrologia: organizzazione e sviluppo della dialisi peritoneale

Governo clinico in nefrologia: organizzazione e sviluppo della dialisi peritoneale

Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

Published: November 07, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026